RHINOSPRAY

This brand name is authorized in Spain

Active ingredients

The drug RHINOSPRAY contains one active pharmaceutical ingredient (API):

1 Tramazoline
UNII 4DG710Q678 - TRAMAZOLINE HYDROCHLORIDE

Tramazoline is an ฮฑ-sympathomimetic agent with local action, which mainly causes vasoconstriction and therefore immediately reduces mucosal edema.

Read about Tramazoline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R01AA09 Tramazoline R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AA Sympathomimetics, plain
Discover more medicines within R01AA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 39574

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈